Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Rabbotti LLC

Neither a doctor nor a teaching hospital

Research payments

$1,036,442

426 payments

Through program year 2025, Rabbotti LLC is reported as receiving $1,036,442 in research payments, across 426 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $131,123 198
2024 Research $5,480 4
2023 Research $278,093 135
2022 Research $493,884 53
2021 Research $111,019 28
2020 Research $8,547 5
2019 Research $8,297 3

Breakdown

Who paid Research payments · program years 2019–2025
  1. LivaNova USA, Inc. $1,020,688 420 payments
  2. Teva Pharmaceuticals USA, Inc. $8,894 4 payments
  3. Ucb SA $6,860 2 payments
Studies the money was for Research payments · program years 2019–2025
  1. A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression $461,475 55 payments
  2. A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) $278,623 38 payments
  3. Recover $200,052 304 payments
  4. The RECOVERsUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes $76,666 18 payments
  5. A Study to Evaluate the Safety, Tolerability, and Effect of Risperidone Extended-Release Injectable Suspension (TV-46000) for Subcutaneous Use as Maintenance Treatment in Adult and Adolescent Patients With Schizophrenia $8,894 4 payments
  6. A Patient- and Investigator-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Bepranemab (Ucb0107) in Study Participants With Prodromal to Mild Alzheimer's Disease (Ad), Followed By An Open-Label Extension Period $6,860 2 payments
  7. TheRECOVERsUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes (UNCOVER) $2,142 2 payments
  8. LivaNova UNCOVER $1,730 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record